NextPlat (NXPL) Net Equity Issued and Repurchased (2012 - 2022)
NextPlat's (NXPL) quarterly Net Equity Issued and Repurchased came in at $8.2 million in Q4 2022, up 46.78% quarter-over-quarter from $5.6 million in Q1 2022.
Powered by 
Analysis
NextPlat (NXPL) Net Equity Issued and Repurchased (2012 - 2022) Analysis & Trends
NextPlat (NXPL) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $8.2 million the latest figure, recorded in Q4 2022.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $8.2 million in Q4 2022; TTM through Sep 2024 was $8.2 million, a 0.0% change from a year earlier, with the FY2023 full-year figure at $6.0 million, down 56.62% from the prior year.
- Net Equity Issued and Repurchased was $8.2 million for Q4 2022 at NextPlat, up from $5.6 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $10.5 million in Q2 2021 and troughed at $5.6 million in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 700,000.00 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | - |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 8.23 Mn |
| Mar 31, 2022 | 5.61 Mn |
| Jun 30, 2021 | 10.46 Mn |
| Dec 31, 2016 | 350,000.00 |
| Dec 31, 2015 | 550,001.00 |
| Mar 31, 2015 | 1.10 Mn |
| Jun 30, 2012 | 550,000.00 |